Defunct Company
Total Trials
25
As Lead Sponsor
24
As Collaborator
1
Total Enrollment
7,350
NCT00576511
Effect of Prucalopride in Patients With Severe Chronic Idiopathic Constipation
Phase: Phase 2
Role: Lead Sponsor
Start: Dec 31, 1994
Completion: Feb 29, 1996
NCT00617513
Efficacy and Safety Study of Prucalopride for the Treatment of Chronic Constipation
Start: Mar 31, 1995
Completion: Mar 31, 1996
NCT00631813
Start: Nov 30, 1995
Completion: Apr 30, 1997
NCT00596596
Trial to Evaluate the Efficacy and Safety of R093877 in Patients With Chronic Idiopathic Constipation
Start: Sep 30, 1996
Completion: Jun 30, 1997
NCT00575614
Prucalopride in Patients With Chronic Idiopathic Constipation
Start: Apr 30, 1997
Completion: Mar 31, 1999
NCT01674192
Prucalopride Subjects With Renal Impairment
Phase: Phase 1
Start: Jul 31, 1997
Completion: Aug 31, 1999
NCT00485940
Efficacy and Safety Study of Prucalopride for the Treatment of Patients With Chronic Constipation
Phase: Phase 3
Start: Mar 31, 1998
Completion: May 31, 1999
NCT00488137
Efficacy and Safety Study of Prucalopride to Treat Chronic Constipation
Completion: Jul 31, 1999
NCT00483886
Start: Apr 30, 1998
NCT01070615
Study to Evaluate Long-Term Tolerability and Safety of Oral Prucalopride in Chronic Constipation
Start: Jun 30, 1998
Completion: Not specified
NCT00987844
Study to Evaluate Long-Term Safety, Tolerability, and Satisfaction With Prucalopride in Chronic Constipation
Start: Jul 31, 1998
NCT00577018
Efficacy and Safety Study of the Effect of Dose-Titration of Prucalopride for The Treatment of Chronic Constipation
Start: Aug 31, 1998
Completion: Sep 30, 1999
NCT00487422
Efficacy and Safety Study of Prucalopride for the Treatment of Elderly Patients With Chronic Constipation
Start: Oct 31, 1998
NCT01670669
Prucalopride in Paediatric Subjects, With Functional Faecal Retention
Start: Nov 30, 1998
NCT01674166
Single Dose Pharmacokinetics of Prucalopride in Paediatric Subjects, With Functional Faecal Retention
NCT00627692
Evaluation of the Safety and Tolerability of Prucalopride in Constipated Elderly Subjects Living in a Nursing Facility
Start: Feb 28, 1999
Completion: May 31, 2000
NCT00598338
Efficacy and Safety Study of Prucalopride for the Re-Treatment of Chronic Constipation
Start: Apr 30, 1999
Completion: Feb 29, 2000
NCT00488215
A Trial in Healthy Volunteers, to Evaluate the Tolerability and Cardiac Safety of Prucalopride
Start: Jan 31, 2000
Completion: Mar 31, 2000
NCT01179607
Study of Efficacy of a Vasopressin 2 Receptor Antagonist M0002 for Treatment of Ascites in Cirrhotic Subjects With Hypo- or Normonatraemia
Start: Jun 30, 2007
Completion: Dec 31, 2007
NCT00903747
Thorough Corrected QT Interval (QTc) Study To Evaluate Possible Effects of Prucalopride on ECG Parameters
Start: Jan 31, 2009
Completion: May 31, 2009
NCT01036893
M0001 Effects on Oral Contraceptive Plasma Levels
Start: Dec 31, 2009
Completion: May 31, 2010
NCT01134185
Evaluation of Prucalopride in Subjects With Moderate and Severe Hepatic Impairment
Start: May 31, 2010
Completion: Feb 28, 2011
NCT05336097
Pathways to Empowerment for Persons Living in Persistent Poverty
Phase: N/A
Role: Collaborator
Start: Apr 4, 2022
Completion: Jul 10, 2023